Pediatric Cardiology

, Volume 38, Issue 8, pp 1598–1605 | Cite as

Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder

  • Meki BiliciEmail author
  • Fikri Demir
  • Alper Akın
  • Mehmet Türe
  • Hasan Balık
  • Mahir Kuyumcu
Original Article


The aim of this study was to evaluate the feasibility, efficacy and safety of transcatheter closure of patent ductus arteriosus (PDA) with the Occlutech duct occluder (ODO) in children. We reviewed the clinical records of 71 patients who underwent percutaneous closure of PDA with an ODO between September 2014 and August 2016. The Occlutech duct occluder was applied to 71 patients during the study period (September 2014–August 2016), and the results were analyzed in this study. Forty-two of the patients were female and 29 male. The median age was 20.5 months (range, 6–194 months) and median weight was 16 kg (range, 6–68 kg). The PDA was classified as type A in 54 patients (76.1%), type E in 14 (19.7%), type C in 2 (2.8%) and type B in 1 (1.4%) based on the Krichenko classification. A standard ODO device was used for the transcatheter closure procedure in 66 patients and the long-shank ODO device in 5. In the echocardiographic measurement of PDA, the median smallest diameter was 2.7 mm (range, 1.5–7.0 mm), and in the angiographic measurement, the median smallest diameter was 2.5 mm (range, 1.5–6.5 mm). All 71 patients underwent successful PDA closure with the ODO. Angiography following the procedure showed complete closure in 47 patients (66.2%), mild residual shunt in 13 patients (18.3%) and a trivial shunt in 11 patients (15.5%). Color flow Doppler echocardiogpaphy at 24 h post-implantation showed that complete closure was achieved in 65 patients (91.5%), and 6 patients (8.5%) had mild residual shunt. All patients (100%) had complete closure at 30 days of follow-up. The results of this study showed that the Occlutech PDA occluder device is safe and effective in the closure of PDA. As the pulmonary artery side of the device is wider than the aortic side, protrusion toward the aortic side and embolization are prevented, but there is residual shunt in the early period, although this residual shunt disappeared after a few months.


Patent ductus arteriosus Children Occlutech duct occluder 


Authors' Contributions

Meki Bilici contributed to the data analysis, drafting the article and statistics. Fikri Demir, Alper Akin, Mehmet Ture and Hasan Balik helped in the data collection, study design and revision of the article. Mahir Kuyumcu contributed to the overall database design, study design and critical revision of the article. Alper Akin and Fikri Demir helped in the study concept and design, data collection and critical revision of the article.

Compliance with Ethical Standards

Conflict of interest

The authors have no commercial or other associations that might pose a conflict of interest in connection to the submitted article. The authors had full control of the design of the study, methods used, outcome parameters, analysis of the data and production of the manuscript.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study (written consent from parents and/or written assent from children).


  1. 1.
    Abdelbasit MA, Alwi M, Kandavello G, Che Mood M, Samion H, Hijazi ZM (2015) The new Occlutech® PDA occluder: initial human experience. Catheter Cardiovasc Inter 86:94–99CrossRefGoogle Scholar
  2. 2.
    Dedeoglu R, Bilici M, Demir F (2016) Short-term outcomes of patent ductus arteriosus closure with new Occlutech® duct occluder: a multicenter study. J Interv Cardiol 29:325–331CrossRefPubMedGoogle Scholar
  3. 3.
    Baruteau AE, Hascoët S, Baruteau J, Boudjemline Y, Lambert V, Angel CY, Belli E, Petit J, Pass R (2014) Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis 107:122–132CrossRefPubMedGoogle Scholar
  4. 4.
    Behjati-Ardakani M, Rafiei M, Behjati-Ardakani MA, Vafaeenasab M, Sarebanhassanabadi M (2015) Long-term results of transcatheter closure of patent ductus arteriosus in adolescents and adults with amplatzer duct occluder. N Am J Med Sci 7:208–211CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ghaderian M, Merajie M, Mortezaeian H, Aarabi Moghadam MY (2013) When can we release the Amplatzer ductal occluder (ADO) safely? J Tehran Heart Cent 8(4):182–186PubMedPubMedCentralGoogle Scholar
  6. 6.
    Kaya Y, Bulut MO, Yurtdaş M, Karakurt A, Güvenç TS, Söylemez N, Güler A, Gönüllü E, Ceylan Y, Akdemir R (2013) Percutaneous closure of patent ductus arteriosus: short term results. Turk Kardiyol Dern Ars 41:310–318CrossRefPubMedGoogle Scholar
  7. 7.
    Baspinar O, Sahin DA, Sulu A, Irdem A, Gokaslan G, Sivasli E, Kilinc M (2015) Transcatheter closure of patent ductus arteriosus in under 6 kg and premature infants. J Interv Cardiol 28:180–189CrossRefPubMedGoogle Scholar
  8. 8.
    Narin N, Pamukçu Ö, Baykan A, Argun M, Özyurt A, Bayram A, Üzüm K (2017) Transcatheter closure of PDA in premature babies less than 2 kg. Anatol J Cardiol 17:147–153. doi: 10.14744/AnatolJCardiol.2016.6847 PubMedGoogle Scholar
  9. 9.
    Lin CC, Hsieh KS, Huang TC, Weng KP (2009) Closure of large patent ductus arteriosus in infants. Am J Cardiol 15:857–861. doi: 10.1016/j.amjcard.2008.11.044 CrossRefGoogle Scholar
  10. 10.
    Parra-Bravo R, Cruz-Ramírez A, Rebolledo-Pineda V, Robles-Cervantes J, Chávez-Fernández A, Beirana-Palencia L et al (2009) Transcatheter closure of patent ductus arteriosus using the amplatzer duct occluder in infants under one year of age. Rev Esp Cardiol 62:867–874CrossRefGoogle Scholar
  11. 11.
    Kudumula V, Taliotis D, Duke C (2015) The new occlutech duct occluder: immediate results, procedural challenges, and short-term follow-up. J Invasive Cardiol 27:250–257PubMedGoogle Scholar
  12. 12.
    Celebi A, Demir IH, Saritaş T, Dedeoğlu R, Yucel IK, Demir F, Erdem A (2013) Cardi-O-Fix duct occluder versus Amplatzer duct occluder for closure of patent ductus arteriosus. Catheter Cardiovasc Interv 15:961–967CrossRefGoogle Scholar
  13. 13.
    Kang SL, Morgan G, Forsey J, Tometzki A, Martin R (2014) Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children. Catheter Cardiovasc Interv 83:1102–1108CrossRefPubMedGoogle Scholar
  14. 14.
    Safaa A, El Sisi A (2016) Transcatheter closure of patent ductus arteriosus in children weighing 10 kg or less: Initial experience at Sohag University Hospital. J Saudi Heart Assoc 28:95–100CrossRefGoogle Scholar
  15. 15.
    Liddy S, Oslizlok P, Walsh KP (2013) Comparison of the results of transcatheter closure of patent ductus arteriosus with newer Amplatzer devices. Catheter Cardiovasc Interv 1:253–259CrossRefGoogle Scholar
  16. 16.
    Ghasemi A, Pandya S, Reddy SV, Turner DR, Du W, Navabi MA, Mirzaaghayan MR, Kiani A, Sloan K, Forbes TJ (2010) Trans-catheter closure of patent ductus arteriosus-What is the best device? Catheter Cardiovasc Interv 76:687–695CrossRefPubMedGoogle Scholar
  17. 17.
    Thanopoulos BV, Ninios V, Dardas P, Giannopoulos A, Deleanou D, Iancovici S (2016) Catheter closure through a venous approach of patent ductus arteriosus in small pediatric patients using combined angiographic and echocardiographic guidance. Am J Cardiol 15:1558–1562. doi: 10.1016/j.amjcard.2016.08.023 CrossRefGoogle Scholar
  18. 18.
    Sungur M, Karakurt C, Ozbarlas N, Baspinar O (2013) Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study. Catheter Cardiovasc Interv 82:245–252CrossRefPubMedGoogle Scholar
  19. 19.
    Karagöz T, Akin A, Ertuğrul I, Aykan HH, Alehan D, Ozer S, Ozkutlu S (2012) Closure of the patent ductus arteriosus with the Amplatzer Duct Occluder II: a clinical experience. Acta Cardiol 67:675–680CrossRefPubMedGoogle Scholar
  20. 20.
    Shabbir M, Akhtar K, Maadullah Ahmed W (2009) Transcatheter closure of large sized patent ductus arteriosus using the amplatzer duct occluder device. J Coll Physicians Surg Pak. 19(5):275–278PubMedGoogle Scholar
  21. 21.
    Boudjemline Y (2016) The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience. Arch Cardiovasc Dis 109:384–389CrossRefPubMedGoogle Scholar
  22. 22.
    Amir Hamzah AR, Tiow CA, Koh GT, Sharifah AM (2011) Transcatheter closure of patent ductus arteriosus: The Penang Hospital’s Experience. Med J Malaysia 66:19–21PubMedGoogle Scholar
  23. 23.
    Cuaso CC, Tan RB, Del Rosario JD, Cheng DD, Reyes KG (2012) Update on the Amplatzer duct occluder: a 10-year experience in Asia. Pediatr Cardiol 33:533–538CrossRefPubMedGoogle Scholar
  24. 24.
    Wang JK, Wu MH, Lin MT, Chiu SN, Chen CA, Chiu HH (2010) Transcatheter closure of moderate-to-large patent ductus arteriosus in infants using Amplatzer duct occluder. Circ J 74:361–364CrossRefPubMedGoogle Scholar
  25. 25.
    Behjati-Ardakani M, Behjati-Ardakani MA, Hosseini SH, Noori N (2013) Long-term results of transcatheter closure of patent ductus arteriosus in infants using amplatzer duct occluder. Iran J Pediatr 23:411–416PubMedPubMedCentralGoogle Scholar
  26. 26.
    Choi DY, Kim NY, Jung MJ, Kim SH (2010) The results of transcatheter occlusion of patent ductus arteriosus: success rate and complications over 12 years in a single center. Korean Circ J 40:230–234CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Abadir S, Boudjemline Y, Rey C, Petit J, Sassolas F, Acar P, Fraisse A, Dauphin C, Piechaud JF, Chantepie A, Lusson JR (2009) Significant persistent ductus arteriosus in infants less or equal to 6 kg: percutaneous closure or surgery? Arch Cardiovasc Dis 102:533–540CrossRefPubMedGoogle Scholar
  28. 28.
    Baykan A, Narin N, Özyurt A, Argun M, Pamukçu Ö, Onan SH, Sezer S, Baykan Z, Üzüm K (2015) Do we need a femoral artery route for transvenous PDA closure in children with ADO-I? Anatol J Cardiol 15:242–247CrossRefPubMedGoogle Scholar
  29. 29.
    Al-Hamash SM, Wahab HA, Khalid ZH, Nasser IV (2012) Transcatheter closure of patent ductus arteriosus using ado device: retrospective study of 149 patients. Heart Views 13:1–6CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Tanıdır IC, Güzeltaş A, Ergül Y, Oztürk E, Ozyılmaz I, Odemiş E (2014) Transcatheter patent ductus arteriosus closure with echocardiographic guidance: can radiation exposure be reduced? Turk Kardiyol Dern Ars 42:643–650CrossRefPubMedGoogle Scholar
  31. 31.
    Demir F, Celebi A, Saritas T, Erdem A, Demir H, Firat MF, Polat TB (2013) Long-term follow-up results of lung perfusion studies after transcatheter closure of patent ductus arteriosus. Congenit Heart Dis 8:159–166CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Department of Pediatric CardiologyDicle University Medical FacultySurTurkey
  2. 2.Department of AnesthesiologyDicle University Medical FacultySurTurkey

Personalised recommendations